Jeuveau is not a filler. It is a neurotoxin, the same category of injectable as Botox and Xeomin. While fillers add volume beneath the skin, Jeuveau works by temporarily relaxing facial muscles to smooth out wrinkles caused by repeated expressions like frowning or squinting. The two treatments do completely different things, and understanding the distinction helps you choose the right one for your goals.
What Jeuveau Actually Is
Jeuveau is a purified form of botulinum toxin type A, produced from a bacterial strain originally isolated from soil in South Korea. It belongs to a class of cosmetic injectables called neuromodulators. These work by blocking the nerve signals that tell muscles to contract. When those muscles relax, the overlying skin looks smoother and less wrinkled.
The FDA approved Jeuveau specifically for the temporary improvement of moderate to severe glabellar lines, the vertical creases that form between your eyebrows when you frown. A standard treatment involves five small injections totaling 20 units across the muscles responsible for that frown pattern. It’s sometimes marketed as “Newtox” because it was the first new neurotoxin to enter the U.S. cosmetic market in nearly a decade.
How Neurotoxins Differ From Fillers
The confusion between Jeuveau and fillers is understandable since both are injected into the face at a cosmetic appointment. But they target entirely different problems through different mechanisms.
Neurotoxins like Jeuveau treat dynamic wrinkles, the lines that appear when your face moves. Crow’s feet when you smile, forehead lines when you raise your eyebrows, frown lines when you concentrate. These wrinkles exist because the same muscles contract thousands of times over years, eventually creasing the skin above them. Jeuveau blocks the chemical signal (acetylcholine) that triggers those contractions, so the muscle relaxes and the crease softens.
Dermal fillers treat static wrinkles, lines that are visible even when your face is completely at rest. They also restore lost volume. Fillers are gel-like substances, most commonly made from hyaluronic acid, that are injected beneath the skin to physically plump up the area. Common filler targets include cheeks, lips, nasolabial folds (the parentheses-shaped lines running from nose to mouth), under-eye hollows, and jawline contouring. Fillers don’t affect muscle movement at all. They simply add structure where tissue has thinned or shifted with age.
What Results Look Like With Jeuveau
Some people notice early changes within 24 to 48 hours after treatment, but the full effect typically takes one to two weeks to develop. The results last roughly three to five months before the nerve signals gradually return and the muscles resume their normal activity. At that point, the wrinkles reappear and you’d need another treatment to maintain the effect.
Because Jeuveau relaxes muscles rather than adding volume, the result is a smoother, more rested appearance in the treated area. Your face won’t look fuller or plumper the way it would after filler. If your concern is deep hollows under your eyes or thin lips, Jeuveau won’t help. If your concern is lines that show up when you make expressions, that’s exactly what it’s designed for.
Can You Use Both Together?
Many people do. A neurotoxin like Jeuveau and a dermal filler address different layers of the aging process, so they complement each other well. For example, you might use Jeuveau to soften frown lines and forehead creases while using a hyaluronic acid filler to restore volume in your cheeks or smooth out nasolabial folds that are visible at rest. Providers sometimes call this a “liquid facelift” when both categories are used in a single session to address multiple concerns at once.
The key is matching the product to the type of wrinkle. Dynamic lines that form with movement respond to neurotoxins. Static lines and volume loss respond to fillers. Using a filler where you need a neurotoxin, or vice versa, won’t give you the result you’re looking for.
How Jeuveau Compares to Botox
Jeuveau and Botox are much closer relatives than Jeuveau and any filler. Both are botulinum toxin type A products, both work by blocking nerve signals to muscles, and both are used to treat expression-related wrinkles. The active ingredient is functionally the same, though the manufacturing and purification processes differ.
One important note: the units used to measure Jeuveau are not interchangeable with units of other botulinum toxin products. A “unit” of Jeuveau is defined by its own potency testing, so 20 units of Jeuveau is not necessarily identical in strength to 20 units of a competing brand. This is why your provider selects dosing based on the specific product being used rather than converting between brands.
In practice, people who have used Botox and switch to Jeuveau often report a similar experience in terms of onset, duration, and overall effect. The choice between the two frequently comes down to provider preference, availability, and cost.